Start for free
Start for free
Broadfin Capital logo

Broadfin Capital

North America, New York, United States, New York

Description

Broadfin Capital is a New-York-based company focused on investments in healthcare companies.

Investor Profile

Broadfin Capital has made 13 investments, with 1 in the past 12 months and 8% as lead.

Stage Focus

  • Post Ipo Equity (77%)
  • Series Unknown (15%)
  • Series C (8%)

Country Focus

  • United States (77%)
  • Ireland (8%)
  • Israel (8%)
  • Canada (8%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Health Diagnostics
  • Oncology
  • Clinical Trials
  • Alternative Medicine
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Broadfin Capital frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 3
3×5 Partners
3×5 Partners
North America, Oregon, United States, Portland
Co-Investments: 1
CA
Cormorant Asset Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Avego Healthcare Capital
Avego Healthcare Capital
North America, Georgia, United States, Alpharetta
Co-Investments: 1
SM
Sabby Management
North America, New Jersey, United States, Saddle River
Co-Investments: 2
Adage Capital Management
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
New Enterprise Associates
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 2
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
CH
Cowen Healthcare Investments
North America, New York, United States, New York
Co-Investments: 1
Deerfield
Deerfield
North America, New York, United States, New York
Co-Investments: 2

Which angels does Broadfin Capital often collaborate with?

DR
Shared Deals: 1

What are some of recent deals done by Broadfin Capital?

Edesa Biotech

Markham, Ontario, Canada

Edesa develops treatments for dermatological and anorectal diseases. Edesa merged with Stellar Biotechnologies in 2019.

BiotechnologyLife Science
Post Ipo EquityFeb 13, 2025
Amount Raised: $10,509,103
Heron Therapeutics

Redwood City, California, United States

Heron Therapeutics is a biotechnology firm specializing in polymer-based pharmaceuticals.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityAug 9, 2022
Amount Raised: $76,500,000
Arch Oncology

St Louis, Missouri, United States

Arch Oncology is a venture-stage biopharmaceutical company.

BiotechnologyMedicalOncologyTherapeutics
Series CApr 27, 2021
Amount Raised: $105,000,000
Sonendo

Laguna Hills, California, United States

Sonendo is a healthcare company that focuses on developing innovative and disruptive technologies to transform endodontic therapy.

BiotechnologyHealth CareMedical
Series UnknownJan 6, 2020
Amount Raised: $85,000,000
Strata Skin Sciences

Horsham, Pennsylvania, United States

Strata Skin Sciences is a medical technology company that specializes in dermatology and plastic surgery.

Health CareMedicalMedical Device
Post Ipo EquityApr 2, 2018
Amount Raised: $17,000,000
Iovance Biotherapeutics

New York, New York, United States

Iovance Biotherapeutics is developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.

BiotechnologyClinical TrialsHealth CareHealth DiagnosticsMedical
Post Ipo EquityJun 3, 2016
Amount Raised: $100,000,000
ContraFect

Yonkers, New York, United States

ContraFect is a biotechnology company researching the use of monoclonal antibodies to treat life-threatening infectious diseases.

BiotechnologyHealth CareMedical
Post Ipo EquityJun 25, 2015
Amount Raised: $20,000,000
Ardelyx

Fremont, California, United States

Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.

BiotechnologyHealth CareMedical
Post Ipo EquityJun 22, 2015
Amount Raised: $77,771,627
Aralez Pharmaceuticals

Brooklyn, New York, United States

Aralez Pharmaceuticals is a global specialty pharmaceutical company.

Alternative MedicineBiotechnologyHealth CareMedical
Post Ipo EquityJun 8, 2015
Amount Raised: $350,000,000
Advaxis

Princeton, New Jersey, United States

Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.

BiotechnologyHealth DiagnosticsPharmaceutical
Post Ipo EquityFeb 19, 2015
Amount Raised: $23,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator